TFRC and ACTB as the best reference genes to quantify Urokinase Plasminogen Activator in breast cancer

BMC Research Notes

Volumn 4, Issue , 2011, Pages

  Majidzadeh A, Keivan ^a   Esmaeili, Rezvan ^a   Abdoli, Nasrin ^a  

^a AVICENNA RESEARCH INSTITUTE   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79959446383     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-4-215     Document Type: Article

References (38)

1. Breast cancer as a global health concern. SC Steven U Donatus E b, Cancer Epidemiology 2009 33 315 318 10.1016/j.canep.2009.10.003 19896917
2. Breast cancer in Iran: an epidemiological review. SM Mousavi A Montazeri MA Mohagheghi AM Jarrahi I Harirchi M Najafi M Ebrahimi, Breast J 2007 13 383 391 10.1111/j.1524-4741.2007.00446.x 17593043 (Pubitemid 46985565)
3. A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer. S Paik S Shak G Tang C Kim J Baker M Cronin FL Baehner MG Walker D Watson T Park,, et al. N Engl J Med 2004 351 2817 2826 10.1056/NEJMoa041588 15591335 (Pubitemid 40051905)
4. American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer. L Harris H Fritsche R Mennel L Norton P Ravdin S Taube MR Somerfield DF Hayes RC Bast Jr, J Clin Oncol 2007 25 5287 5292 10.1200/JCO.2007.14.2364 17954709
5. Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients. M Look W van Putten M Duffy N Harbeck IJ Christensen C Thomssen R Kates F Spyratos M Fernö Thromb Haemost 2003 90 538 548 12958624 (Pubitemid 37142426)
6. Prognostic Value of Urokinase-type Plasminogen Activator in 671 Primary Breast Cancer Patients. JA Foekens M Schmitt WL van Putten HA Peters M Bontenbal F Jänicke JGM Klijn, Cancer Research 1992 52 6101 6105 1394237
7. The Urokinase System of Plasminogen Activation and Prognosis in 2780 Breast Cancer Patients. JA Foekens HA Peters MP Look H Portengen M Schmitt MD Kramer N Brünner F Jänicke MEM-v Gelder SC Henzen-Logmans,, et al. Cancer Research 2000 60 636 643 10676647 (Pubitemid 30094561)
8. Immunoassays (ELISA) of Urokinase-type Masminogen Activator (u.PA): Report of an EORTCIBIOMED-1 Workshop. TJ Benraad J Geurts-Moespot J Grøndahl-Hansen M Schmitt JJ Heuvel JH de Witte J Foekens R Leake N Brünner C Sweep, Eur J Cancer 1996 32A 1371 1381 10.1016/0959-8049(96) 00118-9 8869102
9. Breast Cancer in the 21st Century: Neu Opportunities and Neu Challenges. SJ Schnitt, Mod Pathol 2001 14 213 218 10.1038/modpathol.3880288 11266529 (Pubitemid 32246827)
10. Testing for HER-2/neu in Breast Cancer: Is Fluorescence In Situ Hybridization Superior in Predicting Outcome? H Yaziji AM Gown, Adv Anat Pathol 2002 9 338 344 10.1097/00125480-200211000-00002 12409642
11. The power of real-time PCR. MA Valasek JJ Repa, Adv Physiol Educ 2005 29 151 159 10.1152/advan.00019.2005 16109794 (Pubitemid 41215473)
12. Tech.Sight. A technique whose time has come. NJ Walker, Science 2002 296 557 559 10.1126/science.296.5567.557 11964485
13. FAST DB: a website resource for the study of the expression regulation of human gene products. P de la Grange M Dutertre N Martin D Auboeuf, Nucleic Acids Res 2005 33 4276 4284 10.1093/nar/gki738 16052034 (Pubitemid 41487286)
14. Human housekeeping genes are compact. E Eisenberg EY Levanon, Trends Genet 2003 19 362 365 10.1016/S0168-9525(03)00140-9 12850439 (Pubitemid 36794535)
15. A compendium of gene expression in normal human tissues. LL Hsiao F Dangond T Yoshida R Hong RV Jensen J Misra W Dillon KF Lee KE Clark P Haverty,, et al. Physiol Genomics 2001 7 97 104 11773596
16. Glyceraldehyde-3-phosphate dehydrogenase gene expression in human breast cancer. F Révillion V Pawlowski L Hornez JP Peyrat, Eur J Cancer 2000 36 1038 1042 10.1016/S0959-8049(00)00051-4 10885609 (Pubitemid 30316430)
17. Evaluation and validation of candidate endogenous control genes for real-time quantitative PCR studies of breast cancer. RE McNeill N Miller MJ Kerin, BMC Mol Biol 2007 27 107 119 10.1186/1471-2199-8-107
18. Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes. JB de Kok RW Roelofs BA Giesendorf JL Pennings ET Waas T Feuth DW Swinkels PN Span, Lab Invest 2004 85 154 159 (Pubitemid 40128049)
19. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. J Vandesompele K De Preter F Pattyn B Poppe N Van Roy A De Paepe F Speleman, Genome Biol 2002 3 ESEARCH0034 12184808 10.1186/gb-2002-3-7-research0034
20. Identification of suitable reference genes for gene expression studies of human serous ovarian cancer by real-time polymerase chain reaction. YL Li F Ye Y Hu WG Lu X Xie, Anal Biochem 2009 394 110 116 10.1016/j.ab.2009.07.022 19622337
21. The urokinase plasminogen activator system in cancer: a putative therapeutic target? S Killeen A Hennessey Y El Hassan B Waldron, Drug News Perspect 2008 21 107 116 10.1358/dnp.2008.21.2.1188197 18389102 (Pubitemid 351628235)
22. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. C Andersen J Jensen T Orntoft, Cancer Res 2004 64 5245 5250 10.1158/0008-5472.CAN-04-0496 15289330 (Pubitemid 39006544)
23. Quantitative Real-Time Reverse Transcription-PCR Assay for Urokinase Plasminogen Activator, Plasminogen Activator Inhibitor Type 1, and Tissue Metalloproteinase Inhibitor Type 1 Gene Expressions in Primary Breast Cancer. R Castellá A Estellés C Vázquez C Falcá F Espãa SM Almenar C Fuster J Aznar, Clin Chem 2002 48 1288 1295 12142386 (Pubitemid 34809838)
24. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA. J Biermann L Holzscheiter M Kotzsch T Luther M Kiechle-Bahat F Sweep P Span M Schmitt V Magdolen, Int J Mol Med 2008 21 251 259 18204793 (Pubitemid 351222860)
25. Real-time quantitative PCR determination of urokinase-type plasminogen activator receptor (uPAR) expression of isolated micrometastatic cells from bone marrow of breast cancer patients. JY Pierga C Bonneton H Magdelénat A Vincent-Salomon C Nos E Boudou P Pouillart JP Thiery Pd Cremoux, International Journal of Cancer 2005 114 291 298 10.1002/ijc.20698 (Pubitemid 40194299)
26. HER-2/neu Gene Copy Number Quantified by Real-Time PCR: Comparison of Gene Amplification, Heterozygosity, and Immunohistochemical Status in Breast Cancer Tissue. M Konigshoff J Wilhelm RM Bohle A Pingoud M Hahn, Clin Chem 2003 49 219 229 10.1373/49.2.219 12560343 (Pubitemid 36143442)
27. Quantitative PCR - new diagnostic tool for quantifying specific mRNA and DNA molecules: HER2/neu DNA quantification with LightCycler real-time PCR in comparison with immunohistochemistry and fluorescence in situ hybridization. BO Schlemmer BS Sorensen J Overgaard KE Olsen LM Gjerdrum E Nexo, Scandinavian Journal of Clinical & Laboratory Investigation 2004 64 511 522 10.1080/00365510410002922 21696675
28. Real time RT-PCR approach for the evaluation of ERBB2 overexpression in breast cancer archival samples: a comparative study with FISH, SISH, and immunohistochemistry. E Capizzi E Gruppioni A Grigioni E Gabusi A Grassigli W Grigioni M Fiorentino, Diagn Mol Pathol 2008 17 220 226 10.1097/PDM. 0b013e318161f993 18382352
29. Real-time PCR complements immunohistochemistry in the determination of HER-2/neu status in breast cancer. A Nistor P Watson N Pettigrew K Tabiti A Dawson Y Myal, BMC Clinical Pathology 2006 6 2 10.1186/1472-6890-6-2 16420697
30. Gene transcript assay by real-time RT-PCR in epithelial breast cancer cells selected by laser microdissection. V Becette S Vignaud C Régnier M Labroquére E Fourme E Menet I Bièche F Spyratos, t J Biol Markers 2004 19 100 108 (Pubitemid 39106934)
31. Validation of real-time RT-PCR for analysis of human breast cancer cell lines resistant or sensitive to treatment with antiestrogens. P de Cremoux C Tran-Perennou B Brockdorff E Boudou N Brunner H Magdelenat A Lykkesfeldt, Endocr Relat Cancer 2003 10 409 418 10.1677/erc.0.0100409 14503918 (Pubitemid 37267560)
32. Validation of reference genes for relative real time PCR to study hormone-dependent gene expression in breast cancer biopsies. A Larionov J Dixon A Krause D Evans W Miller, Breast Cancer Res Treat 2005 94
33. Selection of REFERENCE Genes for Normalization of qRT-PCR Data Derived From FFPE Breast Tumors. S Drury H Anderson M Dowsett, Diagnostic Molecular Pathology 2009 18 103 107 10.1097/PDM.0b013e31817c1ae2 19430294
34. Determining suitable internal standards for mRNA quantification of increasing cancer progression in human breast cells by real-time reverse transcriptase polymerase chain reaction. DL Morse D Carroll L Weberg MC Borgstrom J Ranger-Moore RJ Gillies, Analytical Biochemistry 2005 342 69 77 10.1016/j.ab.2005.03.034 15958182 (Pubitemid 40805630)
35. Identification of endogenous reference genes for qRT-PCR analysis in normal matched breast tumor tissues. B Gur-Dedeoglu O Konu B Bozkurt G Ergul S Seckin I Yulug, Oncol Res 2009 17 353 365 10.3727/096504009788428460 19544972
36. Identification of genes for normalization of real-time RT-PCR data in breast carcinomas. M Lyng A Laenkholm N Pallisgaard H Ditzel, BMC Cancer :20 2008 Jan 22 20 10.1186/1471-2407-8-20 (Pubitemid 351689709)
37. De-regulation of common housekeeping genes in hepatocellular carcinoma. S Waxman E Wurmbach, BMC Genomics 2007 18 243 10.1186/1471-2164-8-243
38. Housekeeping genes in cancer: normalization of array data. A Khimani A Mhashilkar A Mikulskis M O'Malley J Liao E Golenko P Mayer S Chada J Killian S Lott, Biotechniques 2005 38 739 745 10.2144/05385ST04 15948292 (Pubitemid 40647043)